From the finding that spontaneous NY-ESO-1-specific T cells are detectable only in seropositive patients, 12 ovarian cancer patients with spontaneous antibody responses against p53 were selected for the evaluation of T cell responses. Here, TP53 is linked to ovarian carcinoma.